INHIBITION OF TUMOR CELL GROWTH, MIGRATION BY SIM-89, A NOVEL INHIBITOR OF C-MET TYROSINE KINASE

被引:0
|
作者
Pei, Jun [1 ]
Chu, Tianqing [1 ]
Shao, Minhua [1 ]
Gu, Aiqing [1 ]
Li, Rong [1 ]
Qian, Jialin [1 ]
Mao, Weifeng [2 ]
Teng, Jiajun [1 ]
Sha, Huifang [3 ]
Li, Yin [1 ]
Han, Baohui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm, Shanghai 200030, Peoples R China
[2] E China Normal Univ, Dept Biol, Shanghai 200062, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Basic Res, Shanghai 200030, Peoples R China
关键词
c-Met; small molecular inhibitor; Lung cancer; cell proliferation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.05-006
引用
收藏
页码:S1063 / S1063
页数:1
相关论文
共 50 条
  • [1] Inhibition of tumor cell growth, invasion, and metastasis by SIM-89, a novel inhibitor of HGF receptor tyrosine kinases
    Pei, Jun
    Han, Baohui
    Shao, Minhua
    Sha, Huifang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met
    Chan, Barden
    VanderLaan, Paul A.
    Sukhatme, Vikas P.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 439 (02) : 247 - 251
  • [3] The inhibition of c-Met and its downstream mTOR induces anti-tumor effect in NSCLC cell line resistant to EGFR tyrosine kinase inhibitor
    Nakachi, Ichiro
    Naoki, Katsuhiko
    Soejima, Kenzo
    Kawada, Ichiro
    Watanabe, Hideo
    Yasuda, Hiroyuki
    Nakayama, Sohei
    Yoda, Satoshi
    Satomi, Ryosuke
    Ikemura, Shinnosuke
    Terai, Hideki
    Ishizaka, Akitoshi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S593 - S594
  • [4] A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers
    Fujita, Ryo
    Blot, Vincent
    Wong, Eley
    Stewart, Christine
    Lieuw, Vincent
    Richardson, Robyn
    Banah, Ammar
    Villicana, Jose
    Timmer, Anjuli
    Coronella, Julia
    Newman, Roland
    Gymnopoulos, Marco
    [J]. CANCER BIOLOGY & THERAPY, 2020, 21 (06) : 549 - 559
  • [5] A selective inhibitor targeting c-Met receptor tyrosine kinase in gastric cancer
    Park, Byung Hee
    Yun, Sun-Mi
    Jung, Kyung Hee
    Lee, Hyunseung
    Hong, Soon-Sun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 350 - 350
  • [6] KRC-327, a selective novel inhibitor of c-Met receptor tyrosine kinase with anticancer activity
    Park, Byung Hee
    Jung, Kyung Hee
    Yun, Sun-Mi
    Hong, Sang-Won
    Ryu, Jae Wook
    Jung, Heejung
    Ha, Jae Du
    Lee, Jongkook
    Hong, Soon-Sun
    [J]. CANCER LETTERS, 2013, 331 (02) : 158 - 166
  • [7] Pharmacological and pharmacokinetc characterization of RP1040, a novel and potent c-Met tyrosine kinase inhibitor
    Viswanadha, Srikant
    Muthuppalaniappan, Meyyappan
    Varanasi, Kanthikiran V. S.
    Veeraraghavan, Sridhar
    Thainashmuthu, Josephrajan
    Murugan, Sivan Perumal
    Kakarla, Prasad Babu
    Kuppireddi, Sumalatha
    Vakkalanka, Swaroop
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [8] ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
    Munshi, Neru
    Jeay, Sebastien
    Li, Youzhi
    Chen, Chang-Rung
    France, Dennis S.
    Ashwell, Mark A.
    Hill, Jason
    Moussa, Magdi M.
    Leggett, David S.
    Li, Chiang J.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1544 - 1553
  • [9] An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
    Guessous, Fadila
    Zhang, Ying
    diPierro, Charles
    Marcinkiewicz, Lukasz
    Sarkaria, Jann
    Schiff, David
    Buchanan, Sean
    Abounader, Roger
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2010, 10 (01) : 28 - 35
  • [10] C-MET IS AMPLIFIED BUT NOT MUTATED IN A CELL-LINE WITH AN ACTIVATED MET TYROSINE KINASE
    PONZETTO, C
    GIORDANO, S
    PEVERALI, F
    DELLAVALLE, G
    ABATE, ML
    VAULA, G
    COMOGLIO, PM
    [J]. ONCOGENE, 1991, 6 (04) : 553 - 559